Gil C / Shutterstock.com
Merck has filed a complaint against Strides Pharma for alleged patent infringement over Sustiva (efavirenz), an antiviral medication that prevents HIV from multiplying in the human body.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
patent, Merck, Strides Pharma, Sustiva, ANDA, FDA